41 devices · GMDN 53027
Gamma-glutamyltransferase (GGT) in vitro diagnostic (IVD) kits use spectrophotometry to measure GGT enzyme levels in blood or other clinical specimens. Clinically, these tests help assess liver function, detect bile duct obstruction, or monitor conditions like alcohol-related liver disease and metabolic disorders.
These kits typically consist of pre-packaged reagents and instructions for laboratory use, often requiring specialized equipment like automated analyzers. Regulation varies by jurisdiction, but they are generally classified as high-risk medical devices due to their role in diagnostic decision-making, requiring compliance with manufacturing, performance, and safety standards.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.